FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • June 28th, 2024 • Artiva Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJune 28th, 2024 Company IndustryTHIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “First Amendment”) is made as of May 9, 2022, by and between ARE-SD REGION NO. 37, LLC, a Delaware limited liability company (“Licensor”), and ARTIVA BIOTHERAPEUTICS, INC., a Delaware corporation (“Licensee”).
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 3rd, 2024 • Artiva Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 3rd, 2024 Company IndustryTHIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “First Amendment”) is made as of May 9, 2022, by and between ARE-SD REGION NO. 37, LLC, a Delaware limited liability company (“Licensor”), and ARTIVA BIOTHERAPEUTICS, INC., a Delaware corporation (“Licensee”).
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • June 6th, 2022 • Artiva Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJune 6th, 2022 Company IndustryTHIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “First Amendment”) is made as of May 9, 2022, by and between ARE-SD REGION NO. 37, LLC, a Delaware limited liability company (“Licensor”), and ARTIVA BIOTHERAPEUTICS, INC., a Delaware corporation (“Licensee”).